Interventions in the House of Commons
 
 
 
RSS feed based on search criteria Export search results - CSV (plain text) Export search results - XML
Add search criteria
View Celina Caesar-Chavannes Profile
Ind. (ON)
View Celina Caesar-Chavannes Profile
2019-06-20 10:13 [p.29464]
, seconded by the member for Vancouver Granville, moved for leave to introduce Bill C-468, An Act to amend the Employment Equity Act.
She said: Mr. Speaker, it gives me great honour to present this bill in what will be my last act as a member of Parliament.
I would first like to offer my condolences to the family and friends of Mr. Mark Warawa, and the community of Langley—Aldergrove. His last speech in this place will be remembered as one of my favourites.
I want to thank the member for Vancouver Granville, a woman I am very proud of and will always continue to stand with.
I want to thank the members of the Liberal government and the NDP for supporting this bill from the outset, and particularly the members for Portage—Lisgar and Oshawa who helped and guided me through this process to get this bill here today. I want to thank Jacqueline Yost, legislative counsel; and the Office of the Law Clerk and Parliamentary Counsel for all of their help in getting me here.
I came to this place to be a voice for all the people I represent, to raise awareness on issues, to move the status quo and to remove barriers.
This bill represents the voices of those both past and present in the federal system. It is my hope that it will examine and help remove the barriers that prevent them, especially those from the black community, from achieving success and promotion within the system. Their voices are reflected in this bill, and it is my honour to bring their voices to this place.
View Jane Philpott Profile
Ind. (ON)
View Jane Philpott Profile
2019-06-19 14:03 [p.29381]
Mr. Speaker, I am delighted to see the final report of the advisory council on pharmacare. I strongly support universal single-payer public pharmacare so Canadians have access to medicines. I hope the recommendations will be implemented.
However, I am concerned about the prices Canadians pay. There has not been progress to reform the Patented Medicine Prices Review Board. In 2017, I proposed regulatory changes to help the PMPRB protect consumers from high prices. This included changing the countries with which we compared prices. We said that value for money should factor into drug prices. We proposed that refunds should be reported to increase transparency and set fair prices. Those changes were to be in place by the end of 2018, but this has not happened.
National pharmacare is essential, but it must be accompanied by good stewardship of public funds. Canadians should not pay the third highest drug prices in the world. I encourage the Minister of Health to proceed with the PMPRB reform without further delay.
View Tony Clement Profile
Ind. (ON)
View Tony Clement Profile
2019-06-19 21:06 [p.29438]
Mr. Speaker, this is a very important trade deal, one I generally support, but I do have concerns about particular items, as do other members of the House.
As someone who was responsible for a time for changes to better protect copyright laws while balancing that with access for consumers, I am always concerned when the Americans bring up copyright. They are always trying to pursue with Canada and with Canadian law watering down some of our protections for consumers: for instance, the notice and take down provisions that the United States tries to push on Canada when it comes to posting on the Internet, and the fair dealing provisions that we have in Canada versus the fair use provisions that are found in the United States.
I am wondering whether the hon. member has a point of view on those issues as well.
Results: 1 - 15 of 270 | Page: 1 of 18

1
2
3
4
5
6
7
8
9
10
>
>|